U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Neoplasms, Hormone-Dependent

MedGen UID:
10218
•Concept ID:
C0027661
•
Neoplastic Process
Synonyms: Hormone Dependent Neoplasms; Hormone-Dependent Neoplasm; Hormone-Dependent Neoplasms; Neoplasm, Hormone-Dependent; Neoplasms, Hormone Dependent

Definition

Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment. [from MeSH]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVNeoplasms, Hormone-Dependent

Professional guidelines

PubMed

Managing menopausal symptoms after cancer: an evidence-based approach for primary care.
Marino JL, McNamara HC, Hickey M
Med J Aust 2018 Feb 19;208(3):127-132. doi: 10.5694/mja17.00693. PMID: 29438648
Management of cancer treatment-induced bone loss in early breast and prostate cancer -- a consensus paper of the Belgian Bone Club.
Body JJ, Bergmann P, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Reginster JY, Rozenberg S, Kaufman JM
Osteoporos Int 2007 Nov;18(11):1439-50. Epub 2007 Aug 10 doi: 10.1007/s00198-007-0439-4. PMID: 17690930
Treatment of breast cancer with gonadotropin-releasing hormone.
Manni A, Santen R, Harvey H, Lipton A, Max D
Endocr Rev 1986 Feb;7(1):89-94. doi: 10.1210/edrv-7-1-89. PMID: 3082618

Recent clinical studies

Etiology

Targeting obesity-related dysfunction in hormonally driven cancers.
Rubinstein MM, Brown KA, Iyengar NM
Br J Cancer 2021 Aug;125(4):495-509. Epub 2021 Apr 28 doi: 10.1038/s41416-021-01393-y. PMID: 33911195Free PMC Article
Triple-negative breast cancer.
Bartsch R, Ziebermayr R, Zielinski CC, Steger GG
Wien Med Wochenschr 2010 Apr;160(7-8):174-81. doi: 10.1007/s10354-010-0773-6. PMID: 20473728
Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer.
Chen WY, Colditz GA
Nat Clin Pract Oncol 2007 Jul;4(7):415-23. doi: 10.1038/ncponc0851. PMID: 17597706
Operable breast cancer.
Cianfrocca M, Goldstein LJ
Curr Treat Options Oncol 2001 Apr;2(2):157-67. doi: 10.1007/s11864-001-0058-9. PMID: 12057134
Hormonal carcinogenesis.
Henderson BE, Feigelson HS
Carcinogenesis 2000 Mar;21(3):427-33. doi: 10.1093/carcin/21.3.427. PMID: 10688862

Diagnosis

Pulmonary lymphangioleiomyomatosis: literature update.
Valentín-Mendoza S, Nieves-Nieves J, Fernández-Medero R, Fernández-Gonzales R, Adorno-Fontánez J, Adorno-Fontánez E
Bol Asoc Med P R 2013;105(3):64-9. PMID: 24282925
MicroRNAs in androgen-dependent PCa.
Zhu KC, Lu JJ, Xu XL, Sun JM
Front Biosci (Landmark Ed) 2013 Jan 1;18(2):748-55. doi: 10.2741/4137. PMID: 23276959
Prostate cancer stem cells.
Tu SM, Lin SH
Clin Genitourin Cancer 2012 Jun;10(2):69-76. Epub 2012 Mar 14 doi: 10.1016/j.clgc.2012.01.002. PMID: 22421313Free PMC Article
The diagnosis and treatment of endometrial cancer: progress and controversies.
Denschlag D, Ulrich U, Emons G
Dtsch Arztebl Int 2010 Aug;108(34-35):571-7. Epub 2010 Aug 29 doi: 10.3238/arztebl.2011.0571. PMID: 21904591Free PMC Article
Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer.
Chen WY, Colditz GA
Nat Clin Pract Oncol 2007 Jul;4(7):415-23. doi: 10.1038/ncponc0851. PMID: 17597706

Therapy

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial.
Kyriakopoulos CE, Chen YH, Carducci MA, Liu G, Jarrard DF, Hahn NM, Shevrin DH, Dreicer R, Hussain M, Eisenberger M, Kohli M, Plimack ER, Vogelzang NJ, Picus J, Cooney MM, Garcia JA, DiPaola RS, Sweeney CJ
J Clin Oncol 2018 Apr 10;36(11):1080-1087. Epub 2018 Jan 31 doi: 10.1200/JCO.2017.75.3657. PMID: 29384722Free PMC Article
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.
Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, Bonnefoi H, Cameron D, Gianni L, Valagussa P, Swain SM, Prowell T, Loibl S, Wickerham DL, Bogaerts J, Baselga J, Perou C, Blumenthal G, Blohmer J, Mamounas EP, Bergh J, Semiglazov V, Justice R, Eidtmann H, Paik S, Piccart M, Sridhara R, Fasching PA, Slaets L, Tang S, Gerber B, Geyer CE Jr, Pazdur R, Ditsch N, Rastogi P, Eiermann W, von Minckwitz G
Lancet 2014 Jul 12;384(9938):164-72. Epub 2014 Feb 14 doi: 10.1016/S0140-6736(13)62422-8. PMID: 24529560
Triple-negative breast cancer.
Bartsch R, Ziebermayr R, Zielinski CC, Steger GG
Wien Med Wochenschr 2010 Apr;160(7-8):174-81. doi: 10.1007/s10354-010-0773-6. PMID: 20473728
Intermittent hormone therapy and its place in the contemporary endocrine treatment of prostate cancer.
Shaw G, Oliver RT
Surg Oncol 2009 Sep;18(3):275-82. Epub 2009 Mar 6 doi: 10.1016/j.suronc.2009.02.003. PMID: 19269165
Adjuvant endocrine therapy.
Rutqvist LE
Best Pract Res Clin Endocrinol Metab 2004 Mar;18(1):81-95. doi: 10.1016/s1521-690x(03)00046-0. PMID: 14687599

Prognosis

Luminal B breast cancer: molecular characterization, clinical management, and future perspectives.
Ades F, Zardavas D, Bozovic-Spasojevic I, Pugliano L, Fumagalli D, de Azambuja E, Viale G, Sotiriou C, Piccart M
J Clin Oncol 2014 Sep 1;32(25):2794-803. Epub 2014 Jul 21 doi: 10.1200/JCO.2013.54.1870. PMID: 25049332
MicroRNAs in androgen-dependent PCa.
Zhu KC, Lu JJ, Xu XL, Sun JM
Front Biosci (Landmark Ed) 2013 Jan 1;18(2):748-55. doi: 10.2741/4137. PMID: 23276959
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
Liedtke C, Mazouni C, Hess KR, André F, Tordai A, Mejia JA, Symmans WF, Gonzalez-Angulo AM, Hennessy B, Green M, Cristofanilli M, Hortobagyi GN, Pusztai L
J Clin Oncol 2008 Mar 10;26(8):1275-81. Epub 2008 Feb 4 doi: 10.1200/JCO.2007.14.4147. PMID: 18250347
Androgen-independent prostate cancer.
Schrijvers D
Recent Results Cancer Res 2007;175:239-49. doi: 10.1007/978-3-540-40901-4_14. PMID: 17432563
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
Breast International Group (BIG) 1-98 Collaborative Group, Thürlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Rabaglio M, Smith I, Wardley A, Price KN, Goldhirsch A
N Engl J Med 2005 Dec 29;353(26):2747-57. doi: 10.1056/NEJMoa052258. PMID: 16382061

Clinical prediction guides

Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers.
Chimento A, De Luca A, Avena P, De Amicis F, Casaburi I, Sirianni R, Pezzi V
Int J Mol Sci 2022 Jan 22;23(3) doi: 10.3390/ijms23031242. PMID: 35163166Free PMC Article
Androgens and esophageal cancer: What do we know?
Sukocheva OA, Li B, Due SL, Hussey DJ, Watson DI
World J Gastroenterol 2015 May 28;21(20):6146-56. doi: 10.3748/wjg.v21.i20.6146. PMID: 26034350Free PMC Article
Soy and its isoflavones: the truth behind the science in breast cancer.
Douglas CC, Johnson SA, Arjmandi BH
Anticancer Agents Med Chem 2013 Oct;13(8):1178-87. doi: 10.2174/18715206113139990320. PMID: 23919747
18F-Fluoroestradiol.
Sundararajan L, Linden HM, Link JM, Krohn KA, Mankoff DA
Semin Nucl Med 2007 Nov;37(6):470-6. doi: 10.1053/j.semnuclmed.2007.08.003. PMID: 17920354
Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer.
Chen WY, Colditz GA
Nat Clin Pract Oncol 2007 Jul;4(7):415-23. doi: 10.1038/ncponc0851. PMID: 17597706

Recent systematic reviews

Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
McFarlane T, Zajac JD, Cheung AS
Clin Endocrinol (Oxf) 2018 Dec;89(6):700-711. Epub 2018 Sep 18 doi: 10.1111/cen.13835. PMID: 30107028
Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Uttley L, Whyte S, Gomersall T, Ren S, Wong R, Chambers D, Tappenden P
Pharmacoeconomics 2017 Jul;35(7):717-726. doi: 10.1007/s40273-016-0481-1. PMID: 27943135
Cardiac glycosides and breast cancer risk: A systematic review and meta-analysis of observational studies.
Karasneh RA, Murray LJ, Cardwell CR
Int J Cancer 2017 Mar 1;140(5):1035-1041. Epub 2016 Nov 27 doi: 10.1002/ijc.30520. PMID: 27861859
Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.
Tucci M, Bertaglia V, Vignani F, Buttigliero C, Fiori C, Porpiglia F, Scagliotti GV, Di Maio M
Eur Urol 2016 Apr;69(4):563-573. Epub 2015 Sep 28 doi: 10.1016/j.eururo.2015.09.013. PMID: 26422676
Systematic review on hormone receptor testing in breast cancer.
Nofech-Mozes S, Vella ET, Dhesy-Thind S, Hagerty KL, Mangu PB, Temin S, Hanna WM
Appl Immunohistochem Mol Morphol 2012 May;20(3):214-63. doi: 10.1097/PAI.0b013e318234aa12. PMID: 22505008

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • MeSH
      Related Medical Subject Headings
    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...